View of Midkine (MK) as a novel biomarker of clinical-subclinical coronary atherosclerosis and related to diabetes mellitus: clinical applications | Anaesthesia, Pain & Intensive Care

Return to Article Details Midkine (MK) as a novel biomarker of clinical-subclinical coronary atherosclerosis and related to diabetes mellitus: clinical applications